共 50 条
Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
被引:0
|作者:
Manisha Korb
Allison Peck
Lindsay N. Alfano
Kenneth I. Berger
Meredith K. James
Nupur Ghoshal
Elise Healzer
Claire Henchcliffe
Shaida Khan
Pradeep P. A. Mammen
Sujata Patel
Gerald Pfeffer
Stuart H. Ralston
Bhaskar Roy
William W. Seeley
Andrea Swenson
Tahseen Mozaffar
Conrad Weihl
Virginia Kimonis
机构:
[1] University of California - Irvine School of Medicine,Department of Neurology
[2] University of California - Irvine School of Medicine,Department of Pediatrics
[3] University of California - Irvine School of Medicine,Department of Pathology & Laboratory Medicine
[4] Cure VCP Disease,Department of Medicine (Pulmonary)
[5] The Abigail Wexner Research Institute at Nationwide Children’s Hospital,The John Walton Muscular Dystrophy Research Centre
[6] NYU Grossman School of Medicine,Department of Neurology and Psychiatry
[7] Newcastle University and Newcastle Hospitals NHS Foundation Trust,Department of Neurology & Neurotherapeutics
[8] Washington University in St. Louis,Department of Medicine (Cardiology)
[9] Thriving Hope Consulting,Hotchkiss Brain Institute
[10] University of Texas Southwestern Medical Center,Department of Neurology
[11] University of Texas Southwestern Medical Center,Weill Institute for Neurosciences
[12] Wellness with Sujata,Department of Neurology
[13] University of Calgary Cumming School of Medicine,Department of Neurology
[14] Institute of Genetics and Cancer at the University of Edinburgh,The Hope Center
[15] Yale School of Medicine,undefined
[16] University of California San Francisco,undefined
[17] University of Iowa Hospitals and Clinics,undefined
[18] Washington University in St. Louis,undefined
[19] Washington University in St. Louis,undefined
来源:
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget’s disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS), among others. An international multidisciplinary consortium of 40+ experts in neuromuscular disease, dementia, movement disorders, psychology, cardiology, pulmonology, physical therapy, occupational therapy, speech and language pathology, nutrition, genetics, integrative medicine, and endocrinology were convened by the patient advocacy organization, Cure VCP Disease, in December 2020 to develop a standard of care for this heterogeneous and under-diagnosed disease. To achieve this goal, working groups collaborated to generate expert consensus recommendations in 10 key areas: genetic diagnosis, myopathy, FTD, PDB, ALS, Charcot Marie Tooth disease (CMT), parkinsonism, cardiomyopathy, pulmonology, supportive therapies, nutrition and supplements, and mental health. In April 2021, facilitated discussion of each working group’s conclusions with consensus building techniques enabled final agreement on the proposed standard of care for VCP patients. Timely referral to a specialty neuromuscular center is recommended to aid in efficient diagnosis of VCP MSP via single-gene testing in the case of a known familial VCP variant, or multi-gene panel sequencing in undifferentiated cases. Additionally, regular and ongoing multidisciplinary team follow up is essential for proactive screening and management of secondary complications. The goal of our consortium is to raise awareness of VCP MSP, expedite the time to accurate diagnosis, define gaps and inequities in patient care, initiate appropriate pharmacotherapies and supportive therapies for optimal management, and elevate the recommended best practices guidelines for multidisciplinary care internationally.
引用
收藏
相关论文